Several drugmakers have been developing lower-cost versions of Novo Nordisk's diabetes drug Ozempic, driving down monthly prices for some users.
from Business News: Get Latest Business News Today along with Share Market updates and Indian Stock Market News | Hindustan Times https://ift.tt/n2KdUjG
from Business News: Get Latest Business News Today along with Share Market updates and Indian Stock Market News | Hindustan Times https://ift.tt/n2KdUjG
